The Impact of Frailty on Outcomes in Dialysis
Overview
Nephrology
Authors
Affiliations
Purpose Of Review: Frailty is highly prevalent in the dialysis population and is associated with mortality. Recent studies have suggested that other dialysis outcomes are compromised in frail individuals. While we do not yet have a consensus as to the best measure of frailty, identification of these poor outcomes and their magnitude of association with frailty will help improve prognostication, allow for earlier interventions, and improve provider-to-patient communication.
Recent Findings: The most widely used assessment of frailty is Fried's physical performance criteria. However, regardless of assessment method, frailty remains highly associated with mortality. More recently, frailty has been associated with falls, fractures, cognitive impairment, vascular access failure, and poor quality of life. Recent large cohort studies provide strong evidence that frailty assessment can provide important prognostic information for providers and patients both before and after initiation of dialysis. Trials aimed at improving frailty are limited and show the promise of augmenting quality of life, although more studies are needed to firmly establish mortality benefits.
Summary: We underscore the importance of frailty as a prognostic indicator and identify other recently established consequences of frailty. Widespread adoption of frailty assessment remains limited and researchers continue to find ways of simplifying the data collection process. Timely and regular assessment of frailty may allow for interventions that can mitigate the onset of poor outcomes and identify actionable targets for dialysis providers.
Pinnam B, Dahiya D, Chandan S, Gangwani M, Ali H, Singh S J Clin Med. 2024; 13(20).
PMID: 39458186 PMC: 11508531. DOI: 10.3390/jcm13206236.
Beyond sarcopenia: frailty in chronic haemodialysis patients.
Souweine J, Pasquier G, Morena M, Patrier L, Rodriguez A, Raynal N Clin Kidney J. 2024; 17(7):sfae069.
PMID: 38983653 PMC: 11231581. DOI: 10.1093/ckj/sfae069.
Frailty syndrome and end-stage kidney disease outcomes at a Latin American dialysis center.
Moreno L, Ruiz C, Urrego J, Cadena M, Maldonado S, Nino D Biomedica. 2024; 43(Sp. 3):21-29.
PMID: 38207151 PMC: 10911819. DOI: 10.7705/biomedica.7057.
Li B, Sang N, Zhang M, Liu Z, Fang R, Liu W Int Urol Nephrol. 2023; 56(2):767-779.
PMID: 37578673 DOI: 10.1007/s11255-023-03739-2.
Use of frailty assessment instruments in nephrology populations: a scoping review.
Kennard A, Rainsford S, Glasgow N, Talaulikar G BMC Geriatr. 2023; 23(1):449.
PMID: 37479978 PMC: 10360289. DOI: 10.1186/s12877-023-04101-y.